Clinical Characteristics of Methicillin-resistant Staphylococcus aureus Infection for Chronic Periprosthetic Hip and

Dong Jin Ryu1, Joon Soon Kang1, Kyoung Ho Moon1

  • 1Department of Orthopedic Surgery, Inha University School of Medicine, Incheon, Korea.

Hip & Pelvis
|August 19, 2016
PubMed
Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) hip and knee arthroplasty infections present with more severe inflammation and slower recovery than methicillin-sensitive Staphylococcus aureus (MSSA) infections, indicating a poorer prognosis.

Area of Science:

  • Orthopedics
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Deep joint infection following hip and knee arthroplasty is a significant clinical challenge.
  • Staphylococcus aureus is a common pathogen in prosthetic joint infections.
  • Distinguishing between methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) infections is crucial for treatment strategies.

Purpose of the Study:

  • To compare the clinical course and laboratory findings of MRSA versus MSSA deep infections after hip and knee arthroplasty.
  • To identify key differences in patient outcomes and inflammatory markers between MRSA and MSSA arthroplasty infections.

Main Methods:

  • Retrospective review of 61 patients with staphylococcal infections post-arthroplasty (36 MRSA, 25 MSSA).
  • Analysis of vital signs, laboratory tests (including CRP and ESR), microbiology, and clinical outcomes.
  • Average follow-up period of 3.8 years.

Main Results:

  • MRSA group exhibited significantly higher initial erythrocyte sedimentation rate, C-reactive protein (CRP), and neutrophil percentage.
  • Normalization of CRP was prolonged in the MRSA group (36.7 days vs. 24.7 days).
  • MRSA infections showed a higher recurrence rate (13.9% vs. 4%), longer interval to staging operations, and increased rates of sepsis-related mortality and limb amputation.

Conclusions:

  • MRSA deep infections post-arthroplasty are associated with more pronounced inflammatory markers and a worse clinical prognosis compared to MSSA.
  • Aggressive treatment approaches are warranted for MRSA infections following hip and knee arthroplasty to improve patient outcomes.